Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults
# Purpose of Review Migraines are prevalent and cause significant morbidity, decline in quality of life and healthcare costs universally. Treatment options are varied, but efficacy is limited. This review centers on Eptinezumab-jjmr, a humanized monoclonal specific to CGRP for the prevention of mig...
Saved in:
Main Authors: | Amnon A. Berger, Joseph Keefe, Cain W. Stark, Matthew Moore, Giovanni F. Ramírez, Julia R. Cucarola, Andrew H. Han, Alan D. Kaye, Latha Ganti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-11-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.38439 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rimegepant for the treatment of migraine
by: Amnon A. Berger, et al.
Published: (2022-10-01) -
Review of Interventional Therapies for Refractory Pediatric Migraine
by: Jacquelin Peck, et al.
Published: (2023-01-01) -
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer’s Disease: A comprehensive review
by: Hannah W. Haddad, et al.
Published: (2022-07-01) -
A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
by: Nazir Noor, et al.
Published: (2022-06-01) -
Literature Review: Pericranial Nerve Blocks for Chronic Migraines
by: Stephanie Wahab, et al.
Published: (2023-04-01)